Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral prednisolone for inflammatory complex regional pain syndrome type 1
NL-OMON43832Phase 4Not yet recruiting
- Sponsor
- Elisabeth-TweeSteden Ziekenhuis
- Start
- Dec 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of prednisolone in Complex Regional Pain Syndrome Type 1 (CRPS-1), sponsored by Elisabeth-TweeSteden Ziekenhuis. Primary endpoint: Clinically important functional improvement on DASH. Planned start Dec 2015; status: not yet recruiting.
02
Drugs
prednisolone
03
Conditions
Complex Regional Pain Syndrome Type 1 (CRPS-1)
Beyond the preview
Go deeper on NL-OMON43832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43832.